Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07224256 · ClinicalTrials.gov registry record · NA
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
A NA study of Stroke and Amyotrophic Lateral Sclerosis, sponsored by Neuralink.
- Recruiting
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT07224256 is a NA study of Stroke and Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Neuralink. The registered enrollment target is 6 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07224256, a NA study of Stroke and Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Neuralink.
- RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The VOICE Study is an early feasibility study to evaluate the initial clinical safety and efficacy of the N1 and R1 Systems device design concept in providing an ability to communicate. The Neuralink N1 Implant is intended to provide the ability to communicate to individuals with severe and irreversible speech production impairment. It is indicated for adults with neurological conditions of the central speech pathways who have impaired upper limb function. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.
Conditions Studied
Interventions
- DEVICE N1 Implant
- DEVICE R1 Robot
Study Locations (1)
Texas
- The University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-10-03 |
| Est. Completion | 2031-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07224256
The ClinicalTrials.gov registry entry for NCT07224256 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Neuralink, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which N1 Implant is the first listed.
NCT07224256 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07224256 about?
NCT07224256 is a clinical study titled "VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration". The VOICE Study is an early feasibility study to evaluate the initial clinical safety and efficacy of the N1 and R1 Systems device design concept in providing an ability to communicate. The Neuralink N1 Implant is intended to provide the ability to communicate to individuals with severe and irrevers...
What is the current status of trial NCT07224256?
This trial is currently recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2025-10-03. Estimated completion is 2031-10.
What conditions does trial NCT07224256 study?
This clinical trial studies the following conditions: Stroke, Amyotrophic Lateral Sclerosis, Cervical Spinal Cord Injury, Tetraplegia/Tetraparesis, Quadriplegia.
What interventions are being tested in trial NCT07224256?
The interventions under investigation include: N1 Implant (DEVICE), R1 Robot (DEVICE).
Who is sponsoring clinical trial NCT07224256?
This trial is sponsored by Neuralink, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07224256 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.